ABBOTT Molecular

As a leader in molecular diagnostics, Abbott is committed to exploring new clinical frontiers through the development and delivery of innovative systems and assay solutions that aid in the diagnosis of diseases, selection of appropriate therapies and monitoring of disease recurrence at the molecular level. Our expanding portfolio in the area of Oncology brings your molecular laboratory multiple technology and platform options. Detection of genetic aberrations in solid tumors with DNA fluorescent in situ hybridization (FISH) probe technology is a powerful means to guide more confident diagnoses and treatment decisions. Molecular testing is making personalized medicine a reality and empowering physicians to improve patient care.